This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
By This Author:
« Back
Page 1 of 2

Human Genome Sciences Perks Up

By Bernie Schaeffer

Shares of the biotech firm rally amid a sharp spike in options activity. Is an FDA ruling coming?

11:58AM 03/02/06

Oil Patch: Buy This Pullback ( $)

By Bernie Schaeffer

Continued signs of complacency are a concern, but technical support should carry the day and the trade.

11:25AM 02/13/06

Vetting VIX Options

By Bernie Schaeffer

Buying VIX calls may prove prohibitively expensive. Selling VIX puts might be an interesting proposition.

12:39PM 02/03/06

Put Your Chips on David vs. Goliath

By Bernie Schaeffer

AMD continues to outshine Intel, but you wouldn't know it judging from the analysts or put/call activity.

11:19AM 01/24/06

Yahoo! Fallout Bodes Well for Amazon ( $)

By Bernie Schaeffer

The online retailer is unloved by analysts and heavily shorted; this is a good setup for contrarian buying.

12:16PM 01/20/06

Don't Believe the Hype

By Bernie Schaeffer

All the 'Dow 11,000' excitement fails to recognize the ongoing woeful performance of big-caps vs. small.

01:16PM 01/12/06

Emerging From Google's Shadow ( $)

By Bernie Schaeffer

Bankrate and Netflix don't get nearly the attention of the search giant, but their shares have performed at least as well.

12:58PM 12/29/05

The Ultimate Contrarian Pick ( $)

By Bernie Schaeffer

With 'everyone' on the big-cap growth bandwagon for 2006, here's the case for small-cap value.

03:05PM 12/27/05

Gold Keeps Its Shine ( $)

By Bernie Schaeffer

A rocky short-term outlook is overshadowed by bullish long-term prospects for the yellow metal.

08:57AM 12/16/05

Utilities: Still Unloved, Still Attractive ( $)

By Bernie Schaeffer

Despite the group's standout performance and attractive yields, the Street stays cold. Therein lies opportunity.

08:00AM 12/06/05

« Back
Page 1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV


DOW 18,162.99 +121.45 0.67%
S&P 500 2,123.48 +19.28 0.92%
NASDAQ 5,106.5930 +73.8420 1.47%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs